Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis.
- DOI
- 10.1016/j.xcrm.2026.103056
- Published
- 2026 Sep 22
- Container
- Cell reports. Medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2026.103056,
title = {Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis.},
author = {Zhang J and Li CM and Fang L and Lin XT and Min K and Wu D and Tan DH and Chen ZY and Zhang LD and Xie CM},
year = {2026},
journal = {Cell reports. Medicine},
doi = {10.1016/j.xcrm.2026.103056},
url = {https://doi.org/10.1016/j.xcrm.2026.103056}
}RIS
TY - JOUR TI - Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis. AU - Zhang J AU - Li CM AU - Fang L AU - Lin XT AU - Min K AU - Wu D AU - Tan DH AU - Chen ZY AU - Zhang LD AU - Xie CM PY - 2026 JO - Cell reports. Medicine DO - 10.1016/j.xcrm.2026.103056 UR - https://doi.org/10.1016/j.xcrm.2026.103056 ER -
APA
J, Z., CM, L., L, F., XT, L., K, M., D, W., DH, T., ZY, C., LD, Z., & CM, X. (2026). Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2026.103056
Source records
- pubmed · retrieved 2026-09-26T10:12:07.952Z